Pop Health Podcast
Join hosts Melissa Cohen and Meg Koepke from Coral Health Advisors as they discuss all things population health, value-based care, and making health care work better for us all.
Pop Health Podcast
Beyond the Hype: What GLP-1s Mean for Policy and Employers
•
Meg and Melissa
•
Season 1
•
Episode 20
GLP-1 medications like Ozempic and Wegovy have quickly moved from niche treatments to the center of high-stakes conversations across payers about cost, access, and coverage. In this episode, Coral Partner Alison Falb talks with Laura Rudder Huff, Vice President at Gallagher Research & Insights, about how the rise of GLP-1s is shaping employer benefit strategies, equity considerations, and policy debates.
